Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

Share Price is delayed by 15 minutes
Get Live Data
47.60    0.00 (0.00%)
Bid:
46.60
Ask:
48.60
Spread: 2.00 (4.292%)
Market Cap: £206.30m
BMD Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead 2vt Share Chart

Update on Fundraising

20 Dec 2021 12:37

RNS Number : 2254W
Baronsmead Second Venture Trust PLC
20 December 2021
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

BARONSMEAD SECOND VENTURE TRUST PLC

LEI: 2138008D3WUMF6TW8C28

20 December 2021

Update on Fundraising

The Board of Baronsmead Second Venture Trust plc (the "Company") announced on 4 November 2021 that the Company, together with Baronsmead Venture Trust plc, had published a prospectus in relation to offers for subscription to raise up to Β£50 million in aggregate with an over-allotment facility to raise up to a further Β£25 million in aggregate (the "Offers"). Full details of the Offers are contained in a prospectus which was published by the Companies on 4 November 2021 (the "Prospectus").

The Directors have been advised that, on the basis of the subscription forms that have been received so far, the Company expects to have raised the initial Β£25 million shortly. Additionally, the Directors have been advised that the pipeline for prospective investments during 2022 is currently strong. As a result, the Board has resolved that it is in the best interests of shareholders to utilise the Over Allotment Facility and subscriptions will be accepted to raise an additional Β£12.5 million, subject to the terms of the Offer. On this basis, if fully subscribed the Company's Offer would raise a total of Β£37.5 million (before costs).

For the avoidance of doubt, the Early Bird Rebate has closed.

Terms used in this announcement have the same meaning as defined in the Prospectus.

Copies of the Prospectus are available until the Offer closes from the Company's website at www.baronsmeadvcts.co.uk/vctoffer and The National Storage Mechanism, https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Further information

For further information please contact:

Baronsmead VCT Investor Relations

020 7382 0999

baronsmeadvcts@greshamhouse.com

Notes

This is a financial promotion and is not intended to be investment advice. The content of this announcement (the "Announcement"), which has been prepared by and is the sole responsibility of the Company, has been approved by Gresham House Asset Management Limited solely for the purposes of section 21(2)(b) of the Financial Services and Markets Act 2000 (as amended).

This Announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the UK Financial Conduct Authority ("FCA") and is not a prospectus. This Announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription of, or solicitation of any offer to subscribe for or to acquire, any ordinary shares in Baronsmead Venture Trust plc or Baronsmead Second Venture Trust plc (together the "Companies") in any jurisdiction, including in or into Australia, Canada, Japan, the Republic of South Africa, the United States or any member state of the EEA (other than any member state of the EEA where the Companies' securities may be lawfully marketed). Investors should not subscribe for or purchase any ordinary shares referred to in this Announcement except on the basis of information in the prospectus (the "Prospectus") in its final form, published today by Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc in connection with the proposed admission of new ordinary shares to the premium segment of the Official List of the FCA and to trading on London Stock Exchange plc's main market for listed securities. A copy of the Prospectus is available for inspection, subject to certain access restrictions, from the Company's registered office, for viewing at the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website (http://www.baronsmeadvcts.co.uk). Approval of the Prospectus by the FCA should not be understood as an endorsement of the securities that are the subject of the Prospectus. Potential investors are recommended to read the Prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with a decision to invest in the Companies' securities.

The distribution of this Announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This Announcement does not constitute, and may not be construed as, an offer to sell, or the solicitation of an offer to acquire or subscribe for, securities of the Companies in any jurisdiction where such offer or solicitation is unlawful or would impose any unfulfilled registration, qualification, publication or approval requirements on the Companies or Dickson Minto W.S. The offer and sale of securities of the Companies has not been and will not be registered under the applicable securities laws of Australia, Canada, Japan, the Republic of South Africa or the United States. Subject to certain exemptions, the securities of the Companies may not be offered to or sold within Australia, Canada, Japan, the Republic of South Africa, the United States or any member state of the EEA or to any national, resident or citizen of Australia, Canada, Japan, the Republic of South Africa, the United States, or any member state of the EEA.

This Announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This Announcement is not an offer of securities for sale into the United States. The securities of the Companies have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered or sold in the United States or to any national, resident or citizen of the United States. No public offering of securities is being made in the United States. In addition, neither of the Companies have been and neither will be registered under the US Investment Company Act of 1940, as amended.

The information in this Announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this Announcement or its accuracy or completeness. This Announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for any securities of the Companies or any other securities nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with, any contract therefor. The material contained in this Announcement is given as at the date of its publication (unless otherwise marked) and is subject to updating, revision and amendment. In particular, any proposals referred to herein are subject to revision and amendment.

This Announcement does not constitute a recommendation concerning the Companies or the Offers. The price and value of securities and any income from them can go down as well as up. Past performance is not a guide to future performance and prospective investors may not receive any return from the Companies. Before purchasing any securities of the Companies, persons viewing this Announcement should ensure that they fully understand and accept the risks set out in the Prospectus. Information in this Announcement or any of the documents relating to the Companies or the Offers cannot be relied upon as a guide to future performance. Potential investors should consult a professional adviser as to the suitability of the Offers for them.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCUROURASUUUAA
Date   Source Headline
28th Jul 202510:00 amRNSNet Asset Value(s)
1st Jul 20255:13 pmRNSTotal Voting Rights
27th Jun 20255:49 pmRNSTransaction in Own Shares
18th Jun 20254:25 pmRNSAllotment of Shares and Total Voting Rights
17th Jun 20257:00 amRNSChange of Allotment Date
11th Jun 20257:00 amRNSHalf-year Report
5th Jun 202512:00 pmRNSNet Asset Value(s)
2nd Jun 20252:19 pmRNSTotal Voting Rights
28th May 202510:20 amRNSClose of Offer to New Applications
7th May 20253:45 pmRNSNet Asset Value(s)
1st May 202511:10 amRNSAllotment of Shares and Total Voting Rights
29th Apr 20254:15 pmRNSNet Asset Value(s)
25th Apr 202512:04 pmRNSEXTENSION OF THE OFFER
3rd Apr 20252:06 pmRNSAllotment of Shares and Total Voting Rights
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20252:36 pmRNSDirector/PDMR Shareholding
13th Mar 20254:16 pmRNSEXTENSION OF THE OFFER
13th Mar 20259:00 amRNSResult of AGM
6th Mar 20253:30 pmRNSNet Asset Value(s)
4th Mar 20255:19 pmRNSTotal Voting Rights
4th Mar 20255:14 pmRNSTransaction in Own Shares
3rd Mar 202511:07 amRNSTotal Voting Rights
26th Feb 20255:30 pmRNSTransaction in Own Shares
24th Feb 20252:01 pmRNSQuarterly Factsheet
21st Feb 20251:09 pmRNSOffer Update:Close of Early Subscription Incentive
20th Feb 20255:19 pmRNSDirector/PDMR Shareholding
20th Feb 20255:19 pmRNSDirector/PDMR Shareholding
20th Feb 20252:30 pmRNSAllotment of Shares and Total Voting Rights
6th Feb 20253:30 pmRNSNet Asset Value(s)
27th Jan 20252:00 pmRNSNet Asset Value(s)
10th Jan 202512:16 pmRNSPublication of Prospectus/Offer for Subscription
3rd Jan 20253:51 pmRNSDirector Declaration
2nd Jan 20257:00 amRNSTotal Voting Rights
24th Dec 20247:00 amRNSAnnual Financial Report
19th Dec 20244:23 pmRNSTransaction in Own Shares
12th Dec 20249:51 amRNSDirector Declaration
5th Dec 20249:45 amRNSNet Asset Value(s)
2nd Dec 202410:14 amRNSTotal Voting Rights
26th Nov 20242:00 pmRNSUpdate on Offer for Subscription
22nd Nov 20247:00 amRNSCompliance with UK Market Abuse Regulation
18th Nov 20246:16 pmRNSTransaction in Own Shares
8th Nov 202412:30 pmRNSNet Asset Value(s)
31st Oct 202410:00 amRNSNet Asset Value(s)
22nd Oct 20244:28 pmRNSNewsletter H2 2024
21st Oct 202410:38 amRNSDirectorate Change
1st Oct 20247:00 amRNSIntention To Fundraise
26th Sep 20243:34 pmRNSDirector/PDMR Shareholding
23rd Sep 20244:20 pmRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSQuarterly Factsheet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.